{
  "company": {
    "name": "ReCode",
    "website": "https://recodetx.com/",
    "record": "https://startuphistory.org/c/recodetx.com"
  },
  "status": null,
  "history_since": "2026-11-12T11:39:29.077Z",
  "baseline": {
    "snapshot_id": "d3a87a6c90d9109d2d56136f5054287faf7044d760d1ea067953af2f561bccbf",
    "observed_at": "2026-11-12T11:39:29.077Z",
    "headline": "Powering the future of genetic medicines with precision delivery",
    "description": "ReCode is the first genetic medicines platform to enable highly targeted delivery to organs, tissues and cells beyond the liver. Our pipeline of rare disease therapeutics uses optimized mRNA and gene ",
    "evidence": "https://recodetx.com/",
    "evidence_kind": "live_capture",
    "facts": {
      "version": 1,
      "pages": [
        {
          "page": "home",
          "customers": [],
          "investors": [],
          "prices": [],
          "compliance": [],
          "funding": [
            "where she led finance and investor relations and raised over $250 million in equity and debt financings including an initial public offering."
          ]
        }
      ]
    },
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-12T11:39:29.077Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2026-11-12T11:39:29.077Z",
      "variants": [
        {
          "headline": "Powering the future of genetic medicines with precision delivery",
          "subhead": "ReCode is the first genetic medicines platform to enable highly targeted delivery to organs, tissues and cells beyond the liver. Our pipeline of rare disease therapeutics uses optimized mRNA and gene ",
          "observed_at": "2026-11-12T11:39:29.077Z",
          "evidence": "https://recodetx.com/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "Powering the future of genetic medicines with precision delivery",
      "subhead": "ReCode is the first genetic medicines platform to enable highly targeted delivery to organs, tissues and cells beyond the liver. Our pipeline of rare disease therapeutics uses optimized mRNA and gene ",
      "from": "2026-11-12T11:39:29.077Z",
      "to": "2026-11-12T11:39:29.077Z",
      "captures": 1,
      "evidence": "https://recodetx.com/",
      "evidence_kind": "live_capture",
      "seen": {
        "on": "2026-11-12T11:39:29.077Z"
      },
      "current": true
    }
  ],
  "changes": [],
  "update": null,
  "same_space": [
    {
      "name": "Redefine",
      "record": "https://startuphistory.org/c/redefine.dev",
      "basis": "description_similarity",
      "category": null
    },
    {
      "name": "PropCode",
      "record": "https://startuphistory.org/c/propcode.com.au",
      "basis": "description_similarity",
      "category": null
    },
    {
      "name": "DeepCode",
      "record": "https://startuphistory.org/c/deepcode.ai",
      "basis": "description_similarity",
      "category": null
    },
    {
      "name": "Roo Code",
      "record": "https://startuphistory.org/c/roocode.com",
      "basis": "description_similarity",
      "category": null
    },
    {
      "name": "RECCE",
      "record": "https://startuphistory.org/c/reccehq.com",
      "basis": "description_similarity",
      "category": null
    }
  ],
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “ReCode” company record, https://startuphistory.org/c/recodetx.com"
}